Rambouillet • Finn crossbred wether lambs were evaluated for differences in longissimus muscle cross-sectional area and overlaying subcutaneous adipose tissue thickness resulting from the use of the beta-agonist clenbuterol. Treatment groups received 0 and 2 ppm clenbuterol in the diet for approximately 40 d prior to slaughter. Longissimus muscle cross-sectional area and fat depth over the 12th-13th rib juncture were measured by real-time ultrasound before and during administration of the compound. At slaughter, muscle metabolism in vitro and carcass characteristics were measured. Based on comparisons with an initial-kill group of sheep, longissimus muscle crosssectional area increased in control sheep by 12% (P>.05) over the 40-d experimental period, and increased in clenbuterol-fed sheep by 48% (P<.05). Conversely, subcutaneous fat thickness increased significantly in the control sheep (88%) during this period, but was unchanged in the clenbuterol-fed animals. Warner-Bratzler shear force values of cooked longissimus samples from clenbuterol-fed sheep were significantly greater than shear force values in cooked samples from control lambs; this was not correlated with the extractable neutral lipid content of the muscle. Simple linear regression between ultrasound and carcass measurements of longissimus muscle cross-sectional area and subcutaneous fat thickness yielded correlation coefficients of .80 and .64, respectively. A significantly greater amount of net glycogen synthesis from [U-a4C] glucose was observed in longissimus muscle strips from clenbuterol-fed animals than in muscle strips from control sheep. As with longissimus muscle cross-sectional area, total glucose utilization in vitro was greatest in the clenbuterol-fed sheep and least in the initial-kill sheep. Palmitate esterification into neutral lipids decreased virtually to zero in muscle from five of the eight clenbuterol-fed sheep. Similarly, the neutral lipid content was 44% lower (P<.05) in longissimus muscle from clenbuterol-fed sheep than in muscle from control sheep. The results suggest that the increased muscle hypertrophy caused by clenbuterol was associated with an increase in the diameter of Type II muscle fiber types.
Introduction
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Received September 26, 1985 . Accepted June 12, 1986 . 1983 ). However, when wether lambs (those traditionally used for meat production) are fed to heavier weights, there is also the negative effect of excess fat production (Riley et al., 1981) . The utilization of nutrients by livestock for the production of fat rather than lean is a loss to both the producer and the packer. This dilemma has led investigators to search for a way to alter the body composition in heavy market weight lambs through diet manipulation and other methods (Crouse et al., 1983) . The beta-agonist clenbuterol increases lean production in cattle and depresses fat accretion . When fed to wether lambs as a top dressing to a finishing diet, clenbuterol increased longissimus muscle surface area by 41% and increased dressing percentage by almost 5% . Clenbuterol decreased fat thickness over the 12th rib by 37%, but had no significant effect on lamb quality grade . Similar results recently have been reported for the beta-agonist cimaterol (Beermann et al., 1986) .
The benefits from the use of clenbuterol and its effectiveness are well documented; however, the mechanism by which clenbuterol acts is still unknown. Therefore, this study was conducted to increase understanding of the effects of the long-term ingestion of beta-agonists on muscle metabolism. Additionally, the efficacy of real-time ultrasound for monitoring differences in lean and fat growth was investigated. This study employed an initial-kill group to establish a baseline with which to compare carcass and metabolic data from control sheep and those fed clenbuterol.
Materials and Methods
Thirty crossbred wether lambs (primarily Rambouillet • Finn) were separated into three groups of 10 lambs based on weight. Sheep were fed twice daily measured amounts of a 67% ground milo diet (table 1); uneaten feed was collected, weighed and re-used. All animals had free access to fresh water. Live weights were recorded at 1-to 2-wk intervals, and longissimus muscle cross-sectional area and fat depth over the longissimus muscle between the 12th and 13th ribs were measured at 2-to 4-wk intervals using an ultrasound instrument s . Cross-sectional area of the longissimus muscle and animal weight were used to cull individuals with lowest performance after 28 d on feed, two or three per group, yielding seven to eight lambs per group.
After 28 d on feed, an initial control group of eight individuals was slaughtered to leave one control and one treatment group. The treatment group received 2 ppm clenbuterol, which was mixed thoroughly with ammonium chloride salt and added to the diet to a final ammonium chloride concentration of 5 g/100 g feed. Ammonium chloride was added to the diet of both groups of sheep at the 5% level to prevent the formation of bladder stones. Clenbuterol was added 7 d after the slaughter of the initialkill groups to allow adaptation to new pen assignments. The final number of sheep in the STechnicare, Johnson and Johnson Co., Ramsey, NJ 07446.
clenbuterol-fed group (eight) was chosen due to the limited amount of available clenbuterol. There was no apparent lamb discomfort or loss of appetite caused by the feeding of clenbuterol. After feeding clenbuterol for 40 d, control and treated animals were selected for slaughter and evaluation based on similar live weight. Three sheep were slaughtered per day for a period of 5 d.
Sections of longissimus dorsi muscle, approximately 3 cm on a side, were taken from each lamb between the 12th and 13th ribs immediately after pelt removal (approximately 10 min postmortem). Samples were placed directly into 35 to 40 C oxygenated Krebs Henseleit buffer (pH 7.4) plus 5 mM glucose. The 15 to 20 min that samples were in this medium prior to incubation with isotopes served as a pre-incubation period. Muscle strips were incubated in vitro for the investigation of glucose metabolism essentially as described by Espinal et al. (1983) . Twenty-to 50-mg strips of tissue (approximately 2 mm in diameter and 10 mm in length) were teased from the muscle samples with forceps and scissors, longitudinally with respect to the fiber direction. The strips of muscle were incubated (free floating) in 3 ml medium containing Krebs Henseleit buffer with 10 mM Hepes buffer (pH 7.4), 5 mM glucose, .75 mM palmitate (potassium salt), 30 mg/ml defatted bovine serum albumin, and 33 mU/ml insulin (Smith, 1984 aThe diet was formulated to provide 12% protein and 7% fiber. Clenbuterol (2 ppm) was mixed thoroughly with the ammonium chloride, which subsequently was mixed with the ground feed in a feed mixer.
bunited trace mineralized salt. United Salt Corp., Houston, TX.
O~/CO2 and placed in a shaking water bath (37 C) for 30 rain (lipid synthesis) or 60 rain (glucose metabolism). The reaction was stopped by the addition of .5 ml 3 N H2SO 4 to the incubation medium.
The measurement of 14C-labeled glucose carbon recovery in glycogen was done according to Espinal et al. (1983) . Determination of CO2 was done as described by Smith (1983) , and 14C-labeled lactate was measured according to the method of Smith and Freedland (1981) . Preliminary experiments in this laboratory indicated that, in muscle samples placed in oxygenated, buffered medium containing 5 mM glucose during handling, the production of CO2 from [UJ4C]glucose is linear over time (up to 90 min) and with tissue weight (up to 50 mg muscle tissue).
Palmitate esterification was measured as described by Etherton and Allen (1980) . Neutral lipids were extracted as described by Smith and Prior (1982) . Lipid synthesis in muscle strips incubated in vitro was shown to be linear with time up to 60 min in preliminary studies. As detailed by Etherton and Allen (1980) , fatty acid pool dilution was minimized by using a short incubation time (30 min) and a high concentration of palmitate (.75 mM). Additionally, the potential for dilution of labeled palmitate by fatty acid release from intracellular stores is substantially less in muscle than in adipose tissue, due to the lesser lipid content of muscle.
All radioactivity was measured in a liquid scintillation counter 6. Chemicals were purchased from Fisher Scientific 7, Sigma Chemical Co. s or J. T. Baker Chemicals 9. Radioisotopes were purchased from New England Nuclear 1~
Carcasses were stored at 2 C and evaluated 48 h postmortem. USDA yield and quality grades were determined by Texas A&M personnel after a 24-h chill at 2 to 3 C according to USDA (1982) standards. Longissimus chops (2.54 cm thick) were cooked on open-hearth grills to an internal temperature of 70 C. After cooling for 2 h, triplicate 1.3-cm diameter cores were removed parallel to the orientation 6 Beckman model LS 3800, Beckman Instruments, Palo Alto, CA.
Fisher Scientific, Fair Lawn, NJ. s Sigma Chemical Co., St. Louis, MO. 9j. T. Baker Chemical Co., Phillipsburg, NJ. 10New England Nuclear, Boston, MA. of the muscle fiber for Warner-Bratzler shear force determination. Neutral lipids were extracted from duplicate 1-g samples of uncooked, previously frozen longissimus muscle by the procedure of Smith and Prior (1982) .
Data were analyzed with the General Linear Model program (SAS, 1982) ; when statistical difference was noted (P<.05), means were separated by Duncans multiple range test (Ott, 1984) .
Results
Since feed intake data were based on single pen measurements for each treatment group, feed intake and feed efficiency could not be analyzed statistically. However, there was no apparent difference in feed intake between control and clenbuterol-fed sheep (figure 1). Nor was there a significant difference in live body weight at each of the weighing periods (table 2) . Therefore, there was no need to adjust subsequent comparisons to a constant body weight.
Longissimus muscle cross-sectional area and subcutaneous adipose tissue thickness, obtained by real-time ultrasound measurements at 21, 35 and 70 d on trial (-14, 0 and 35 d on clenbuterol), did not differ (P>.05) between treatment groups (table 2) . However, the trend (P<.10) for increased longissimus muscle cross-sectional area was similar to differences observed in carcass measurements (table 3) .
There was a significant decrease in flank streaking in clenbuterol-treated lambs (table 3) . However, quality grades did not differ (P>.05) between control and clenbuterol lambs due to the superior carcass conformation in the clenbuterol-fed group. Leg conformation was increased from Choice 61 in control lambs to Prime 3s in lambs fed clenbuterol (P<.05).
As suggested by the real-time ultrasound data, fat thickness was significantly less in clenbuterol lambs than in control lambs, but not less than that of the initial group (P>.05). Only the clenbuterol-fed lambs exhibited a significant increase in longissimus muscle crosssectional area relative to the initial group; the control group muscle area was not greater (P>.05) than that of the initial group. The greater amount of subcutaneous and kidney-pelvic fat in the control group was reflected in a significantly greater yield grade, relative to the initial group. The percentage of kidney-pelvic fat was greater (P<.05) in the clenbuterol-fed group than in the initial group, but was not greater than that in the control group (table 3) . The relatively high percentage of kidney-pelvic fat in the clenbuterol-fed sheep resulted in there being no differences (P>.05) in USDA yield grade relative to the control group or the initial-kill group of sheep.
Cooked longissimus muscle from the clenbuterol-fed sheep exhibited nearly twofold greater Warner-Bratzler shear force values than muscle from control sheep (table 3). The control shear force value (2.78 kg) was lower than values reported by others (e.g., Smith et al., 1976) .
Real-time ultrasound overestimated longissimus muscle cross-sectional area by 7 to 17%, and underestimated subcutaneous fat thickness by 19 to 35%, relative to carcass measurements. The overestimation of muscle cross-sectional area by ultrasound was particularly pronounced for those muscles with the largest diameters. The regression of carcass data against ultrasound measurements indicated that real-time ultrasound more accurately predicted longissimus muscle cross-sectional area than subcutaneous fat thickness (figure 2). Only one of the seven control sheep had a longissimus muscle cross-sectional area larger than the clenbuterol-fed sheep (figure 2).
Muscle from the initial-kill group of sheep displayed greater rates of CO2 production than muscle from the control sheep (P<.05), but CO2 production in muscle from the initial group was not different from that observed in muscle from clenbuterol-fed sheep (table 4) . Lactate production and total glucose utilization were not significantly different between samples from clenbuterol-fed and control lambs; however, both lactate production and total glucose utilization were greater in muscle strips from the clenbuterol-fed sheep than in muscle strips from the initial group of sheep (P<.05).
The conversion of glucose to glycogen was markedly higher in muscle from clenbuterol-fed lambs than in muscle from controls (P<.05), and tended to be greater than glycogen synthesis in muscle from the initial group (P<.10; table 4). The ratio of lactate:glycogen production from glucose observed in this study (25: Bottom. Regression of subcutaneous fat thickness measured on the carcass (y-axis) against that measured by real-time ultrasound (x-axis) for control (o) and clenbuterol-fed (e) sheep (r = .64). dMean (SD) for two animals for the initial group not compared statistically to control and clenbuterol groups.
muscle from the control sheep) was greater than the ratio reported for rat soleus muscle strips (10:1; Espinal et al., 1983) . This ratio decreased to 15:1 in longissimus muscle strips from the clenbuterol-fed sheep (table 4) . The rates of CO2 and glycogen production in muscle from both groups of sheep indicated that the muscle strips were well-oxygenated and viable. The incorporation of palmitate into neutral lipids in muscle strips incubated in vitro did not differ (P>.05) between treatment groups (table  4) . However, the extractable neutral lipid content of longissimus muscle from clenbuterol-fed sheep was 44% lower (P<.05) than in control sheep (table 3). In muscle from the control group, there was a modest correlation between muscle neutral lipid content and palmitate esterification rates (r = .66; figure 3) . Muscle from only three of the eight clenbuterol-fed animals displayed measurable rates of lipid synthesis, and there was no significant correlation between palmitate esterification rates and lipid content (r = .21; figure 3 ). These calculations included values of 0 for those samples in which no palmitate esterification was detectable. Since longissimus muscle from clenbuterol-fed sheep contained less lipid than muscle from control sheep, it is unlikely that the negligible rates of lipid synthesis in vitro were due to radioisotope pool dilution.
Discussion
Through the use of real-time ultrasound, it was possible to measure differences in the growth of body components important in yield grading lambs. Furthermore, the ultrasound measurement of longissimus muscle crosssectional area and backfat thickness ensured that treatment groups were not significantly different prior to feeding clenbuterol. This is especially important in studies utililzing small numbers of animals.
It is likely that compression of subcutaneous fat by the hide in the living animal was responsible for the underestimation of fat thickness observed when using real-time ultrasound. Additionally, stretching of the lamb carcass on the rail may have resulted in a smaller longissimus muscle surface area on the carcass than that predicted by real-time ultrasound. From these data, it is apparent that real-time ultrasound is useful for monitoring growth of specific muscle and adipose tissue sites, but may not be applicable to predicting carcass characteristics quantitatively.
The tendency for muscle from clenbuterolfed sheep to utilize glucose at greater rates (especially relative to muscle from the initialkill group of sheep) was indicative of a greater proportion of Type II fibers. This was supported by the marked hypertrophy of the muscle (which typically is due to enlargement of Type II fibers), by the lower lipid content of the muscle (typical of Type II fibers), and by the observation that muscle from five of the eight sheep fed clenbuterol did not esterify radiolabeled palmitate at measureable rates (also typical of Type II fibers).
A recent report (Beermann et al., 1985) indicated that the increase in semitendinosus muscle observed in sheep fed the beta-agonist cimaterol was due to equal increases in the diameters of all fiber types. However, Wu et al. (1986) demonstrated' that feeding clenbuterol to heifers resulted only in increases in Type II fiber diameters in longissimus muscle, with no increase in the diameter of Type I fibers. Whether the difference in results reported by Beermann et al. (1985) and Wu et al. (1986) were due to species or muscle differences is unknown.
The lower muscle lipid content and increased Warner-Bratzler shear force in meat from clenbuterol-fed sheep suggested a correlation between the two. However, simple linear regression between extractable neutral lipid content and shear force yielded a coefficient of determination (r 2 • 100) of only 30.0. The lower subcutaneous fat covering of clenbuterol-fed sheep could have resulted in cold-shortening of the muscle as the carcasses cooled (Smith et al., 1976) . However, the magnitude of the increase in shear force (114%) was much greater than values reported previously (Smith et al., 1976) , which suggests that some other factor besides cold-shortening also was involved in the increased toughness of the meat. Additionally, increases in shear force have been observed in muscle from heifers fed clenbuterol, in which significant decreases in subcutaneous fat thickness were not observed (M. E. Coleman and S. B. Smith, unpublished observations). Higher Warner-Bratzler shear force values typically result in lower tenderness ratings by trained taste panelists (e.g., Smith et al., 1976) and could markedly influence consumer acceptance of meat from animals fed beta-agonists. Thus, more research must be done to define the basis for this observation.
The only fat depot that was not decreased by clenbuterol was that of kidney and pelvic fat. This may have occurred from feeding clenbuterol too late in the growth phase, when the internal fat had already been deposited. However, Beermann et al. (1986) indicated that Dorset wether lambs slaughtered at 31 kg and 38 kg (7 wk and 12 wk of treatment, respectively) exhibited significant reductions in kidney-pelvic fat due to cimaterol feeding. It is likely that both beta-agonists have similar modes of action, so the differences observed between this study and that of Beermann et al. (1986) may have been related to differences in breed type. The Rambouillet • Finn sheep used in this study demonstrated somewhat lower dressing percentages and smaller longissimus areas than the Dorset wether lambs used by Beermann et al. (1986) . Furthermore, the wether lambs used in this study grew substantially more slowly (approximately 200 g/d) than those used by Beermann et al. (1986) , even though the sheep were fed a concentrated finishing ration.
The use of real-time ultrasound and an initial-kill group of sheep has added a new dimension to our understanding of the effects of beta-agonists on subcutaneous adipose tissue accretion in sheep: clenbuterol did not decrease subcutaneous fat thickness to values below those observed before the administration of the compound. Instead, clenbuterol merely halted the further increase in subcutaneous adipose tissue thickness typically observed in growing sheep fed a high energy diet. The improvement of carcass characteristics through the use of clenbuterol has been shown previously by Baker et al. (1984) , when lambs were fed varying amounts of the beta-agonist for 8 wk. Significant increases in longissimus muscle cross-sectional area, carcass and leg conformation grade and a significant decrease in the external fat covering were achieved in just 40 d in the present study. Beermann et al. (1986) indicated significant improvements in carcass traits after feeding the beta-agonist cimaterol for 5 wk. The shorter feeding times of the more recent reports, relative to that reported by Baker et al. (1984) , are an added advantage for the producer in the use of clenbuterol-type drugs.
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